Development of a combined cardiac and aortic transplant model to investigate the development of transplant arteriosclerosis in the mouse.

BACKGROUND: The degree of transplant arteriosclerosis in murine cardiac allografts is difficult to assess. Aortic allografts represent an alternative model for evaluating the impact of novel transplant strategies on transplant arteriosclerosis in which the vascular changes can be quantified easily....

Full description

Bibliographic Details
Main Authors: Ensminger, S, Billing, J, Morris, P, Wood, K
Format: Journal article
Language:English
Published: 2000
_version_ 1826296688282697728
author Ensminger, S
Billing, J
Morris, P
Wood, K
author_facet Ensminger, S
Billing, J
Morris, P
Wood, K
author_sort Ensminger, S
collection OXFORD
description BACKGROUND: The degree of transplant arteriosclerosis in murine cardiac allografts is difficult to assess. Aortic allografts represent an alternative model for evaluating the impact of novel transplant strategies on transplant arteriosclerosis in which the vascular changes can be quantified easily. However, it remains controversial as to whether vascular lesions seen in this model are equivalent to those that develop in solid-organ transplants. The aim of this study was to develop a model of combined cardiac and aortic transplantation to allow more precise quantification of transplant arteriosclerosis and to establish a correlation between the lesions that develop in the 2 types of graft. METHODS: CBA (H2(k)) recipients received a C57BL/10 (H2(b)) cervical cardiac allograft on Day 0 and a C57BL/10 (H2(b)) abdominal aortic allograft on Day 1. Recipients were treated with anti-CD154 mAb (MR1) on Days 0, 2, and 4. We performed histology and morphometric measurements for both grafts 30 days after transplantation. RESULTS: We observed significant intimal proliferation in both the cervical cardiac and abdominal aortic allografts from recipients treated with anti-CD154 mAb (heart, 64% +/- 9%; aorta, 67% +/- 8%; n = 5). Abdominal aortic grafts transplanted alone into anti-CD154-treated recipients developed a degree of transplant arteriosclerosis equivalent to that seen in the aortic grafts of the combined group (aorta alone, 68% +/- 9%, vs aorta + heart, 67% +/- 8%; n = 5). CONCLUSIONS: This combined cardiac and aortic transplant model permitted quantitative assessment of transplant arteriosclerosis while monitoring graft survival by cardiac palpation. Furthermore, development of transplant arteriosclerosis was equivalent in abdominal aortic allografts either in the presence or absence of an additional solid- organ transplant.
first_indexed 2024-03-07T04:20:12Z
format Journal article
id oxford-uuid:cac3103c-8fbe-4910-9ad7-cc988baac9dc
institution University of Oxford
language English
last_indexed 2024-03-07T04:20:12Z
publishDate 2000
record_format dspace
spelling oxford-uuid:cac3103c-8fbe-4910-9ad7-cc988baac9dc2022-03-27T07:09:41ZDevelopment of a combined cardiac and aortic transplant model to investigate the development of transplant arteriosclerosis in the mouse.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:cac3103c-8fbe-4910-9ad7-cc988baac9dcEnglishSymplectic Elements at Oxford2000Ensminger, SBilling, JMorris, PWood, KBACKGROUND: The degree of transplant arteriosclerosis in murine cardiac allografts is difficult to assess. Aortic allografts represent an alternative model for evaluating the impact of novel transplant strategies on transplant arteriosclerosis in which the vascular changes can be quantified easily. However, it remains controversial as to whether vascular lesions seen in this model are equivalent to those that develop in solid-organ transplants. The aim of this study was to develop a model of combined cardiac and aortic transplantation to allow more precise quantification of transplant arteriosclerosis and to establish a correlation between the lesions that develop in the 2 types of graft. METHODS: CBA (H2(k)) recipients received a C57BL/10 (H2(b)) cervical cardiac allograft on Day 0 and a C57BL/10 (H2(b)) abdominal aortic allograft on Day 1. Recipients were treated with anti-CD154 mAb (MR1) on Days 0, 2, and 4. We performed histology and morphometric measurements for both grafts 30 days after transplantation. RESULTS: We observed significant intimal proliferation in both the cervical cardiac and abdominal aortic allografts from recipients treated with anti-CD154 mAb (heart, 64% +/- 9%; aorta, 67% +/- 8%; n = 5). Abdominal aortic grafts transplanted alone into anti-CD154-treated recipients developed a degree of transplant arteriosclerosis equivalent to that seen in the aortic grafts of the combined group (aorta alone, 68% +/- 9%, vs aorta + heart, 67% +/- 8%; n = 5). CONCLUSIONS: This combined cardiac and aortic transplant model permitted quantitative assessment of transplant arteriosclerosis while monitoring graft survival by cardiac palpation. Furthermore, development of transplant arteriosclerosis was equivalent in abdominal aortic allografts either in the presence or absence of an additional solid- organ transplant.
spellingShingle Ensminger, S
Billing, J
Morris, P
Wood, K
Development of a combined cardiac and aortic transplant model to investigate the development of transplant arteriosclerosis in the mouse.
title Development of a combined cardiac and aortic transplant model to investigate the development of transplant arteriosclerosis in the mouse.
title_full Development of a combined cardiac and aortic transplant model to investigate the development of transplant arteriosclerosis in the mouse.
title_fullStr Development of a combined cardiac and aortic transplant model to investigate the development of transplant arteriosclerosis in the mouse.
title_full_unstemmed Development of a combined cardiac and aortic transplant model to investigate the development of transplant arteriosclerosis in the mouse.
title_short Development of a combined cardiac and aortic transplant model to investigate the development of transplant arteriosclerosis in the mouse.
title_sort development of a combined cardiac and aortic transplant model to investigate the development of transplant arteriosclerosis in the mouse
work_keys_str_mv AT ensmingers developmentofacombinedcardiacandaortictransplantmodeltoinvestigatethedevelopmentoftransplantarteriosclerosisinthemouse
AT billingj developmentofacombinedcardiacandaortictransplantmodeltoinvestigatethedevelopmentoftransplantarteriosclerosisinthemouse
AT morrisp developmentofacombinedcardiacandaortictransplantmodeltoinvestigatethedevelopmentoftransplantarteriosclerosisinthemouse
AT woodk developmentofacombinedcardiacandaortictransplantmodeltoinvestigatethedevelopmentoftransplantarteriosclerosisinthemouse